Donor-Derived Cell-Free DNA (Dd-Cfdna) and Clinical Outcomes in Heart Transplant (Ht) Patients (Pts) with Antibody Mediated Rejection (Amr): Protect Study

Authors

• S. Hall
• B. C. Lampert
• D. G. Biagini
• G. Gude
• N. Kaur
• M. Olympios
• S. A. Carey
• Celeste T. Williams, Henry Ford HealthFollow
• C. A. Gupta
• G. D. Lewis

Recommended Citation

Hall S, Lampert BC, Biagini DG, Gude G, Kaur N, Olympios M, Carey SA, Williams CT, Gupta CA, Lewis GD. Donor-Derived Cell-Free DNA (Dd-Cfdna) and Clinical Outcomes in Heart Transplant (Ht) Patients (Pts) with Antibody Mediated Rejection (Amr): Protect Study. Am J Transplant 2026; 26(7):S873-S873.

Document Type

Conference Proceeding

Publication Date

6-19-2026

Publication Title

Am J Transplant

Keywords

Surgery, Transplantation

Volume

26

Issue

7

First Page

S873

Last Page

S873